Explore our comprehensive coverage of crispr, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The modern medical research ecosystem is constrained by structural bottlenecks in delivery, economics, and regulation, despite scientific breakthrough...
Read Full Story →
PoliticsThe first patient to receive a 10-gene edited porcine heart has survived for 12 months, marking a hi...
PoliticsThe FDA has approved NeuroEdit-AD, the first in vivo CRISPR gene therapy for Alzheimer's disease. Th...
GadgetsIn 2026, in vivo gene therapies and CRISPR cures for rare diseases are becoming standard care, highl...
GadgetsThe CRISPR clinical landscape in 2026 has expanded to over 250 active trials, moving beyond sickle c...
HealthcareLandmark Phase 1b/2 trial data reveals that a single-dose in-vivo CRISPR base editing therapy target...
BusinessMedical researchers have successfully transplanted 10-gene edited pig kidneys into human recipients,...
